Supplementation of IL-22 may be an effective treatment, and local IL-22 gene delivery improves intestinal inflammation by enhanced signal transducer and activator of transcription 3 (STAT3) activation within colonic epithelial cells in the murine model of ulcerative colitis (210). This evidence concerns the gene STAT3 and ulcerative colitis.